Development of Minimally-Invasive Cartilage Reshaping Device

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43DC012258-01
Agency Tracking Number: R43DC012258
Amount: $157,600.00
Phase: Phase I
Program: SBIR
Awards Year: 2012
Solicitation Year: 2012
Solicitation Topic Code: NIDCD
Solicitation Number: PA11-096
Small Business Information
DUNS: 965542124
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 (949) 371-6226
Business Contact
Phone: (949) 371-6226
Research Institution
DESCRIPTION (provided by applicant): Every year, more than 600,000 operations are performed to alter the shape of the structural cartilage frameworks of the ear (otoplasty) and nose (rhinoplasty and septoplasty) for both functional and aesthetic purposes,accounting for more than 1 billion in expenditure. Current methods of reshaping cartilage in the head, face and upper airway require carving, cutting, suturing, or crushing this viscoelastic biologic charged polymer into a new desired shape in order tobalance the innate forces that resist deformation. The results are highly variable and dependent on the skills and techniques of the surgeon. In addition to the usual risk factors related to conventional surgical interventions, there is an increased healthcare cost due to hospital expenses and loss of productivity due to patient down-time for recovery (e.g., anesthesia, O.R. fees, overnight stays). Praxis Biosciences, LLC aims to develop and deliver a paradigm-shifting minimally-invasive electromechanical cartilage re-shaping device without the unnecessary risks and costs of traditional cut and suture surgery. In addition, the minimally invasive ultra low-cost nature of the proposed technology will allow surgeons to titrate and perform sequential treatments over time on a given patient in order to alter facial cartilage shape in a measured step-wise fashion, avoiding drastic and noticeable changes that occur with conventional surgery. The proposed device is based on the fact that cartilage mechanicalproperties change in response to low-level, low-current DC electric fields. Efficacy has already been demonstrated in vivo animal models. In this phase I SBIR proposal, we will build and test a clinic-ready prototype for cartilage re-shaping. Upon successful completion, the device will be used to carry out a first pilot human trial in future Phase II proposals. PUBLIC HEALTH RELEVANCE: More than 600,000 operations are performed each year to treat nasal airway obstruction or to correct external eardeformities. These surgical interventions can add to the cost of care and patient down-time. The proposed product based on a novel electro-mechanical forming of cartilage will enable office-based minimally- invasive treatments at affordable cost.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government